BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC)

Q: What does CUSIP 07725L102 represent in this 13F holders report?

CUSIP 07725L102 is the security identifier for ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share in Q1 2018?

122 institutional investors reported ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share for Q1 2018. Use the holders table for investor-level position and value details.

CUSIP: 07725L102

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Ordinary shares, par value $0.0001 per share
Shares outstanding: 1,385,160,313
Total 13F shares: 36,449,398
Share change: +8,886,183
Total reported value: $6,123,436,880
Put/Call ratio: 19%
Price per share: $168.00
Number of holders: 122
Value change: +$1,501,911,684
Number of buys: 81
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 07725L102:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q1 2018

As of 31 Mar 2018, BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,449,398 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Hillhouse Capital Management, Ltd., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Temasek Holdings (Private) Ltd, PRICE T ROWE ASSOCIATES INC /MD/, CANADA PENSION PLAN INVESTMENT BOARD, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, and PRIMECAP MANAGEMENT CO/CA/. This page lists 122 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.